A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol-Myers Squibb advances healthcare with CAR T therapy trials; company supports patient accessibility with travel aid for lupus study participants, emphasizing commitment to equitable treatment

Bristol Myers Squibb Q2 revenues rise 9% to $12.2B; GAAP EPS at $0.83, Non-GAAP EPS at $2.07, driven by commercial execution and pipeline advancement

Researchers Submit Patent Application, 'Methods Of In Vitro Dissolution', for Approval (USPTO 20240226821)

Bristol-Myers Squibb advances healthcare with economic analyses and global cancer fundraising; 350 employees from 30 countries participating in Country 2 Country 4 Cancer ride

Bristol-Myers Squibb Co. Champions Advancements in Multiple Sclerosis Treatment and Cognitive Health with AI and Documentary Support

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count